Regulatory role of Sirt1 on the gene expression of fatty acid-binding protein 3 in cultured porcine adipocytes

Journal of Cellular Biochemistry

Volumn 107, Issue 5, 2009, Pages 984-991

  Shan, Ti Z ^a   Ren, Yang ^a   Wu, Ting ^a   Liu, Chen X ^a   Wang, Yi Z ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b NONE   (China)

Author keywords

FABP3; Nicotinamide; Pig; PPAR ; Resveratrol; RNA interference; Sirt1

Indexed keywords

FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 3; NICOTINAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESVERATROL; SIRTUIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; NONHUMAN; OBESITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA EXTRACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

ADIPOCYTES; ANIMALS; CELLS, CULTURED; DOWN-REGULATION; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; NIACINAMIDE; PPAR GAMMA; RNA, SMALL INTERFERING; SIRTUINS; STILBENES; SUS SCROFA; TIME FACTORS; UP-REGULATION;

SUIDAE; SUS;

EID: 67749089175     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22203     Document Type: Article

References (44)

1. Adida A, Spener F. 2006. Adipocyte-type fatty acid-binding protein as intercompartmental shuttle for peroxisome proliferator activated receptor gamma agonists in cultured cell. Biochim Biophys Acta 1761:172-181.
2. Backesjo CM, Li YU, Haldosen LA. 2006. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Miner Res 21:993-1002.
3. Bai L, Pang WJ, Yang YJ, Yang GS. 2008. Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem 307:129-140.
4. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363-366.
5. Binas B. 2005. Heart and liver fatty acid binding proteins and the metabolic syndrome. Curr Hypertens Rep 7:401-406.
6. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA. 2002. Inhibition of silencing and accelerated aging by nicotinamide, a putafivenegative regulator of yeast sir2 and human Sirt1. J Biol Chem 277:45099-45107.
7. Chen CH, Lin EC, Cheng WT, Sun HS, Mersmann HJ, Ding ST. 2006. Abundantly expressed genes in pig adipose tissue: An expressed sequence tag approach. J Anim Sci 84:2673-2683.
8. Chmurzynska A. 2006. The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism. J Appl Genet 47:39-48.
9. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
10. Erol E, Cline GW, Kim JK, Taegtmeyer H, Binas B. 2004. Nonacute effects of H-FABP deficiency on skeletal muscle glucose uptake in vitro. Am J Physiol 287:E977-E982.
11. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811.
12. Furuhashi M, Hotamisligil GS. 2008. Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:489-503.
13. Gardan D, Louveau I, Gondret F. 2007. Adipocyte- and heart-type fatty acid binding proteins are both expressed in subcutaneous and intramuscular porcine (Sus scrofa) adipocytes. Comp Biochem Physiol Part B Biochem Mol Biol 148:14-19.
14. Gerbens F, van Erp AJ, Harders FL, Verburg FJ, Meuwissen TH, Veerkamp JH, te Pas MF. 1999. Effect of genetic variants of the heart fatty acid-binding protein gene on intramuscular fat and performance traits in pigs. J Anim Sci 77:846-852.
15. Glatz JF, Schaap FG, Binas B, Bonen A, van der Vusse GJ, Luiken JJ. 2003. Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle. Acta Physiol Scand 178:367-371.
16. Haunerland NH, Spener F. 2004. Fatty acid-binding proteins-insights from genetic manipulations. Prog Lipid Res 43:328-349.
17. Jackson MD, Schmidt MT, Oppenheimer NJ, Denu JM. 2003. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases. J Biol Chem 2278:50985-50998.
18. Kawabe K, Saegusa H, Seto K, Urabe H, Motojima K. 2005. Peroxisome proliferatoractivated receptor alpha and its response element are required but not sufficient for transcriptional activation of the mouse heart-type fatty acid binding protein gene. Int J Biochem Cell Biol 37:1534-1546.
19. Kim EJ, Kho JH, Kangand MR, Um SJ. 2007. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 28:277-290.
20. Kim SH, Park HS, Lee MS, Cho YJ, Kim YS, Hwang JT, Sung MJ, Kim MS, Kwon DY. 2008. Vitisin A inhibits adipocyte differentiation through cell cycle arrest in 3T3-L1 cells. Biochem Biophys Res Commun 372:108-113.
21. Kitamura YI, Kitamura T, Kruse JP, Raum JC, Stein R, Accili D. 2005. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab 2:153-163.
22. Knouff C, Auwerx J. 2004. Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: Lessons from genetics and pharmacology. Endocr Rev 25:899-918.
23. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T. 2002. Human SIR2 deacetylates p53 and antagonizes PML/ p53-induced cellular senescence. EMBO J 21:2383-2396.
24. Li B, Zerby HN, Lee K. 2007. Heart fatty acid binding protein is upregulated during porcine adipocyte development. J Anim Sci 85:1651-1659.
25. -ΔΔCT method. Methods 25:402-408.
26. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L. 2004. Mammalian SIRT1 represses forkhead transcription factors. Cell 116:551-563.
27. Murphy EJ, Barcelo-Coblijn G, Binas B, Glatz JF. 2004. Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice. J Biol Chem 279:34481-34488.
28. Pervaiz S. 2003. Resveratrol: From grapevines to mammalian biology. FASEB J 17:1975-1985.
29. Picard F, Guarente L. 2005. Molecular links between aging and adipose tissue. Int J Obes 29:S36-S39.
30. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW, Guarente L. 2004. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429:771-776.
31. Qiang L, Wang H, Farmer SR. 2007. Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-Lα. Mol Cell Biol 27:4698-4707.
32. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. 2005. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434:113-118.
33. Samulin J, Berget I, Lien S, Sundvold H. 2008. Differential gene expression of fatty acid binding proteins during porcine adipogenesis. Comp Biochem Physiol B Biochem Mol Biol 151:147-152.
34. Schachtrup C, Emmler T, Bleck B, Sandqvist A, Spener F. 2004. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins. Biochem J 382:239-245.
35. Schmitt B, Flück M, Décombaz J, Kreis R, Boesch C, Wittwer M, Graber F, Vogt M, Howald H, Hoppeler H. 2003. Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurancetrained athletes. Physiol Genomics 15:148-157.
36. Shan T, Wang Y, Wu T, Guo J, Liu J, Feng J, Xu Z. 2008. Porcine adipose triglyseride lipase gene clone, expression pattern and regulation by resveratrol. J Anim Sci 86:1781-1788.
37. Storch J, Corsico B. 2008. The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu Rev Nutr 28:73-95.
38. Szczerbal I, Chmurzynska A, Switonski M. 2007. Cytogenetic mapping of eight genes encoding fatty acid binding proteins (FABPs) in the pig genome. Cytogenet Genome Res 118:63-66.
39. Wolf G. 2006. Calorie restriction increases life span: A molecular mechanism. Nutr Rev 64:89-92.
40. Xia H, Mao Q, Paulson HL, Davidson BL. 2002. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 20:1006-1010.
41. Xu Y, Mirmalek-Sani SH, Yang X, Zhang J, Oreffo RO. 2006. The use of small interfering RNAs to inhibit adipocyte differentiation in human preadipocytes and fetal-femur-derived mesenchymal cells. Exp Cell Res 312:1856-1864.
42. Yang B, Brown KK, Chen L, Carrick KM, Clifton LG, McNulty JA, Winegar DA, Strum JC, Stimpson SA, Pahel GL. 2004. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats. BMC Pharmacol 18(4):23.
43. Zaripheh S, Nara TY, Nakamura MT, Erdman JW Jr. 2006. Dietary lycopene downregulates carotenoid 15,159-monooxygenase and PPAR-g in selected rat tissues. J Nutr 136:932-938.
44. Zimmerman AW, Veerkamp JH. 1998. Members of the fatty acid-binding protein family inhibit cell-free protein synthesis. FEBS Lett 437:183-186.